Overview

Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors

Status:
Completed
Trial end date:
2019-06-28
Target enrollment:
Participant gender:
Summary
Evaluate the treatment of tamoxifen of low/intermediate-risk bladder tumors
Phase:
Phase 2
Details
Lead Sponsor:
Baylor College of Medicine
Collaborator:
National Cancer Institute (NCI)
Treatments:
Citric Acid
Tamoxifen